Table 3 Profile of patients initiated on gabapentin in Belgium between 2008 and 2014 who were in specialized alcohol and drug treatment or not
In specialized treatment (N = 649, 2.7%) | Not in specialized treatment (N = 872, 0.7%) | |||
|---|---|---|---|---|
N | % | N | % | |
Sex | ||||
Male | 382 | 58.9% | 503 | 57.7% |
Female | 267 | 41.1% | 369 | 42.3% |
Age categories | ||||
15 y–19 y | 5 | 0.8% | 4 | 0.5% |
20 y–29 y | 48 | 7.4% | 59 | 6.8% |
30 y–39 y | 135 | 20.8% | 145 | 16.6% |
40 y–49 y | 184 | 28.4% | 264 | 30.3% |
50 y–59 y | 188 | 29.0% | 275 | 31.5% |
≥ 60 y | 89 | 13.7% | 125 | 14.3% |
Received prescription gabapentin | ||||
only inpatient | 88 | 13.6% | 34 | 3.9% |
only outpatient | 337 | 51.9% | 693 | 79.5% |
in- and outpatient | 224 | 34.5% | 145 | 16.6% |
Initiation to gabapentin | ||||
in outpatient service | 469 | 72.3% | 789 | 90.5% |
in inpatient service | 180 | 27.7% | 83 | 9.5% |
Number of prescriptions received per patient –only outpatient prescriptions | ||||
1 | 247 | 38.1% | 411 | 47.1% |
2 | 98 | 15.1% | 137 | 15.7% |
3 | 50 | 7.7% | 43 | 4.9% |
4 | 42 | 6.5% | 48 | 5.5% |
5 | 25 | 3.9% | 23 | 2.6% |
6–10 | 69 | 10.6% | 87 | 10.0% |
11–20 | 72 | 11.1% | 62 | 7.1% |
+20 | 46 | 7.1% | 61 | 7.0% |
Times of abuse (>3600mg/day) – only outpatient prescriptions | ||||
0 | 505 | 90.0% | 756 | 90.2% |
1 | 36 | 6.4% | 51 | 6.1% |
2 | 10 | 1.8% | 9 | 1.1% |
3–10 | 6 | 1.1% | 21 | 2.5% |
11–20 | 3 | 0.5% | 1 | 0.1% |
+20 | 1 | 0.2% | 0 | 0.0% |
Total abusers | 56 | 10.0% | 82 | 9.8% |
Total users (outpatient only) | 561 | 838 | ||